David McTurk - JDRF Chair
I am an electronics engineer by training and have been deeply involved in building advanced technology manufacturing businesses for most of my career. I have my own Change Management company but at the moment I am fully engaged as Chief Operating Officer of ZapGo Ltd. My daughter, Sarah, was diagnosed with type 1 diabetes when she was 11 which was a life changing moment for the whole family and the condition has been a significant influence on our lives ever since, bringing some bad times but also a lot of inner strength to all of us. I have been involved with JDRF since 2002 and first served on the Board from then until 2008 when I became Chair of the Trading Company. I re-joined the Board in March 2017 and became its Chairman in January 2019. I love JDRF for what it does, for the purity of its mission, and for the terrific team, led by the extraordinary and inspiring CEO, Karen. I know we will rid the world of type 1 diabetes and being part of this mission is deeply important to me and to all of us.
JDRF Treasurer, Executive Committee Member, Former Partner at PwC and a Chartered Accountant. I have type 1 diabetes and was diagnosed over 40 years ago. I am now starting to confront some of the wider medical issues arising from having had type 1 for an extended period and realistically, given my age, I don't see a personal benefit from a type 1 cure. However I feel very passionate about achieving a cure so that others do not have to deal with managing that delicate blood sugar level balance, or cope with the consequences when it goes wrong. This extends beyond those who have type 1 to all those who love and live with them. If we can put a man on the moon...
Currently Group CEO of STRAT7, a data driven strategy group; plus Non-Executive Chair, Director and Board Advisor to a portfolio of public and private companies, including SThree plc (a specialist STEM recruiter), Performance IO (a healthcare performance marketing agency), Firstlight PR (corporate communications), Shootsta (a global video production company) and Board Director of JDRF. I have spent thirty years working in global media and marketing groups holding a variety of senior roles in UK, Europe and North America advising clients across multiple industries. I was first introduced to JDRF nearly ten years ago, when my niece was diagnosed with type 1 diabetes. In 2014, my nine year old son was also then diagnosed and the condition has become an everyday battle for both our families. I am delighted to be part of the JDRF team to achieve its very clear mission of improving the lives of those afflicted by type 1 as well as finding a cure as quickly as possible.
Chief Executive Officer of Aon Benfield, JDRF Board Director - My daughter Julia was diagnosed with type 1 aged just four years old on 14 January 2002. My family and I choose to support JDRF because of its focus on type 1 medical research and its commitment to drive and deliver improvements in treatment until we find the cure for type 1 diabetes. I believe the JDRF global research programme is the best hope for the cure and for a future for Julia without type 1. I do all I can personally and professionally to help JDRF, and I am proud to be a member of the Board.
International banker with corporate finance and private banking experience; JDRF Board Director and Director of JDRF Trading Ltd. One of my daughters, Alexandra, has lived with type 1 diabetes for many years. Following her diagnosis our family wanted to learn as much as possible about the condition and contribute in some way to finding the cure which is why we got in touch with JDRF. This is the second term I have served on the Board and it's exciting to see how much JDRF as an organisation has developed and the great strides that have been made within research that will help cure, treat and prevent type 1. It's a hugely exciting time to be part of JDRF's work and I am honoured to have been asked to serve a second term.
Managing Director, Corporate Strategic Initiatives PMO at BNY Mellon. JDRF Board Director - Both my niece and nephew were diagnosed with type 1 diabetes in their teenage years and I saw at close hand the dramatic effect this had on their lives and that of my sister. A cure would mean a world free of constant worry for all who have to manage this chronic and life-changing condition. I choose to support JDRF because of its laser-like focus and commitment to finding the cure and am honoured to sit on its board.
James M Lurie
Corporate Attorney and Partner at Wollmuth Maher & Deutsch, JDRF Board Director - My brother and niece both have type 1 diabetes. The cure would be a dream come true for our family, the completion of a sacred promise I made to my brother and parents that I wouldn’t stop until a cure is found. Not to have to worry about complications, about daily shots and blood testing. To see the smile on my niece’s face that she no longer has to worry about any of these things. But what will be the cure? What ‘cures’ my brother and niece and others with type 1 diabetes may necessitate different remedies and then how do we be make sure that my and my brother’s grandchildren don’t become afflicted with type 1 diabetes? The research must go on. We need your help. There is a cure out there and together we can and will find it.
Editorial Director of The Sunday Times and Chair of Women in Journalism - My twin god-daughters have type 1 and a childhood friend died from its complications so the science of how we can make life safer and easier for those who have the condition has long been a passion of mine. I am dedicated to working with JDRF and am proud to be putting my professional, political and social contacts to good use in order to raise awareness of type 1 and ultimately find the cure.